Chemoinformaics analysis of 2,6,10,15-TETRAMETHYLHEPTADECANE
| Molecular Weight | 296.583 | nRot | 14 |
| Heavy Atom Molecular Weight | 252.231 | nRig | 0 |
| Exact Molecular Weight | 296.344 | nRing | 0 |
| Solubility: LogS | -7.328 | nHRing | 0 |
| Solubility: LogP | 9.185 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 65 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 64.4089 |
| nHD | 0 | BPOL | 44.1411 |
| QED | 0.286 |
| Synth | 3.095 |
| Natural Product Likeliness | 0.664 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.019 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.613 |
| MDCK | 0.00000592 |
| BBB | 0.358 |
| PPB | 0.982589 |
| VDSS | 3.012 |
| FU | 0.01847 |
| CYP1A2-inh | 0.163 |
| CYP1A2-sub | 0.176 |
| CYP2c19-inh | 0.252 |
| CYP2c19-sub | 0.409 |
| CYP2c9-inh | 0.222 |
| CYP2c9-sub | 0.935 |
| CYP2d6-inh | 0.024 |
| CYP2d6-sub | 0.02 |
| CYP3a4-inh | 0.17 |
| CYP3a4-sub | 0.105 |
| CL | 6.403 |
| T12 | 0.022 |
| hERG | 0.051 |
| Ames | 0.005 |
| ROA | 0.013 |
| SkinSen | 0.948 |
| Carcinogencity | 0.029 |
| EI | 0.927 |
| Respiratory | 0.125 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.610004 |